Biomedical subjects
Publications and source records attributed to D Ayli.
We report a previously healthy, immunocompetent 17-year-old male patient, who developed acute glomerulonephritis during the course of Parvovirus B19 infection and this acute glomerulonephritis did not resolve spontaneously. His renal biopsy showed mild mesangial proliferation and focal segmental sclerosis. Parvovirus B19 DNA was detected in renal tissue by polymerase chain reaction.
BACKGROUND: Immediate accessibility of a newly implanted dialysis graft is desirable to avoid temporary catheters. The most commonly used dialysis graft, expanded polytetrafluorethylene (ePTFE), does not allow early access. This report presents the first clinical data regarding the immediate puncturability of a newly introduced "self-sealing" polycarbonate urethane graft (PUG). METHODS: Patients implanted with a PUG due to the need for immediate vascular access through their new grafts were followed prospectively for early and late complications. RESULTS: Five patients who were implanted with a PUG were dialyzed through their grafts within hours after surgery. Dialysis was continued three times per week in each patient, without a puncture-related problem. CONCLUSION: The availability of a self-sealing graft allowing immediate vascular access on the same day of the implant was achieved with the PUG system. Decreasing the need for temporary catheters may initiate some of the complications associated with hemodialysis.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
In chronic renal failure patients many factors may predispose to stone formation following renal transplantation. Urinary calculi occur in transplanted cases in 0.3 to 6.3%. ESWL, percutaneous nephrolithotomy or open surgical treatment is usually necessary to treat these patients. In this study we present a patient transplanted from a living donor at our centre. Stone formation developed 3 months after the operation and ureteropelvic obstruction was corrected by open surgical intervention.
In this first clinical trial femoral vein transposition (FVT) was prospectively compared with its "graft" counterpart. Patients requiring vascular access due to occluded central veins were divided into two groups: group I (n = 17) underwent femoral loop grafts and group II (n = 15), FVT. Complications were recorded prospectively and patency rates were compared by the Kaplan Meier method with statistical comparisons by Mann Whitney U and chi-square tests as appropriate. Between 1999 and 2003 30 patients underwent 32 operations. Mean follow-up was 8.9 months in group I and 6.8 months in group II (P >.05). Three group I patients developed a steal, requiring closure of the fistula in one. Five group II patients developed a steal, requiring closure of the fistula in one. The incidence of steal was similar in both groups (P >.05). The infection rates were similar: 35.3% and 26.7% in group I versus group II (P >.05), respectively. Among the six infections in group I, four patients required excision of the graft due to infection, whereas only one arteriovenous fistula (AVF) was closed in group II for infection. The 1-year primary patency rate in group I was 37.5% versus 86.7% in group II (P <.05). In conclusion, Femoral AVF grafts have been condemned because of the unacceptable high rate of septic complications. FVT obviates the need for a graft and has fewer infectious problems and better patency rates.
The rate of patients with exhausted upper extremity arteriovenous fistula (AVF) sites who have lost all chances for a conventional upper extremity AVF has been increasing in line with the general increase in the hemodialysis patient population. In this prospective study, we report the early and late follow-up results of "exotic" AVFs in which central veins are used for the outflow. Patients having no chance for an upper extremity AVF based on previous catheterization, surgical AVF history, detailed physical examination, and radiological assessment, were included in the study. Between June 1999 and January 2003, 27 central AVFs were created with a 6 mm synthetic vascular graft in 26 patients. The inflow artery was the proximal axillary artery in all except one. All but one operation was done by the same surgeon. The outflow vein was the internal jugular vein in 16 and infraclavicular axillary vein in 11 cases. One-year primary and secondary graft patency rates were 33.33 +/- 10.49 and 57.06 +/- 11.29, respectively. The early complications were facial edema and hemiparesis, both of which resolved spontaneously. The only late complication, pseudoaneursym, was treated by a graft interposition. In selected patients who have no suitable upper extremity vessels for an AVF, the central veins may be used with an acceptable success rate. Another advantage of this procedure is the avoidance of undesired femoral interventions; sometimes it may be the only opportunity and lifesaving for the patient.